By the end of this webinar, participants will be able to:

• Recognise mRNA vaccines technologies

• Identify results of published and ongoing clinical studies

• Validate effective mRNA-based cancer immunotherapies

• Identify the benefits and risks of using mRNA anti-cancer vaccines